Search results for " opportunity"
Article
Modular Manufacturing Platforms for Biologics
Emel writes on CRB’s website, “Being able to compress project schedules also allows manufacturers the opportunity to delay investment, allowing them to further scrutinize market data, or conversely, s…
Article
Challenges and Trends in Biopharma Facility Design
These advantages include further reduction in manufacturing footprint and [capital expenditures], in combination with an opportunity for more robust processing because there is a higher degree of auto…
Article
Regulatory Challenges in the QbD Paradigm
The authors demonstrate how an integrated model is helping to achieve regulatory flexibility. This article is part of a special section on biopharmaceutical trends.
With the dawn of the 2…
Article
Evaluating the Use of Continuous Chromatography
Continuous processes continue to advance in bioprocessing. In downstream processing, continuous chromatography is gaining traction in the purification of protein therapeutics. As the biopharma…
Article
Digitalization: The Route to Biopharma 4.0
The biopharma industry is still in transition from manual to automated operations, thereby offering an opportunity to incorporate Industry 4.0. Early efforts indicate that multiple challenges are enco…
Article
Maximum Output Starts with Optimized Upstream Processing
By Cynthia A. Challener
Biopharmaceutical companies and contract manufacturers respond to changing demand dynamics for upstream bioprocessing capacity.
Significant growth in the develo…
Article
Single-Use Technologies Prove Effective for Viral Vector Process Development
The emphasis on speed to market in the fast-growing gene therapy segment also presents an opportunity for technology providers to deliver valuable, sustainable solutions that help viral-vector manufac…
Article
Remote Monitoring and Big Data Advance Upstream Automation
“The confluence of big data with an increase in computing power provides companies the opportunity to conquer high-value problems, which historically were too complex and unscalable to solve,” she say…
Article
Process Development: 2020 Reflections and 2021 Possibilities
The challenges posed by the COVID-19 pandemic in 2020 brought about many unprecedented lessons and promising developments in the biopharmaceutical industry. Last year in particular reenforced the ne…
Article
Good Manufacturing Practices: Challenges with Compliance
WrightStudio/Stock.Adobe.com
The complexity of biologics and the use of new technologies present challenges for complying with CGMPs.
By Lauren Lavelle
…